Moderna Sales Could Drop on Weakening COVID-19 Vaccine Demand
- Investing News
admin
- 0
- 1 minute read
Moderna (MRNA) reports third-quarter earnings before the market opens on Nov. 3. Profit is expected to decline by two-thirds as revenue drops for the first time in 11 quarters.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-956821300-b29b779991de44d6af762bfb4f909fdf.jpg "<div>Could Google's New Quantum Chip Mean Your Bitcoin Could Soon Be Hacked?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/modern-analyst-1316900_1920-f70c674fb760412fa184a505a51c5c2d.jpg "Common Interview Questions for Credit Risk Analysts")
:max_bytes(150000):strip_icc():format(jpeg)/SECForm425-41087544bb054a868ccbeb13482beb63.jpg "What Does a Chief Financial Officer (CFO) Do?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2159746556-2e3b77ab7fc54f1b97c114d57974e4f1.jpg "What Happens to Your Money When Your Fintech Company Goes Bust?")